{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:34:00Z","timestamp":1787585640208,"version":"build-2736575974"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012286","name":"Deputy for Research and Technology, Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","award":["4020843"],"award-info":[{"award-number":["4020843"]}],"id":[{"id":"10.13039\/501100012286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-026-05249-x","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:23:09Z","timestamp":1783074189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pistacia atlantica sub. Kurdica can improve insulin resistance in patients with non-alcoholic fatty liver disease: a randomized clinical trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Roghayeh","family":"Mostafaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mostafa","family":"Nachvak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Mahaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Jalilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Behbood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Gharib","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Heidarpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roghaye Farhadi","family":"Hassankiadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"issue":"2","key":"5249_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/antiox10020174","volume":"10","author":"JC Arroyave-Ospina","year":"2021","unstructured":"Arroyave-Ospina JC, Wu Z, Geng Y, Moshage H. Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy. Antioxidants. 2021;10(2):174.","journal-title":"Antioxidants"},{"issue":"12","key":"5249_CR2","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Nonalcoholic steatohepatitis: a review. JAMA. 2020;323(12):1175\u201383.","journal-title":"JAMA"},{"issue":"1","key":"5249_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1210\/endrev\/bnz009","volume":"41","author":"T Marjot","year":"2020","unstructured":"Marjot T, Moolla A, Cobbold JF, Hodson L, Tomlinson JW. Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management. Endocr Rev. 2020;41(1):66\u2013117.","journal-title":"Endocr Rev"},{"key":"5249_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s11901-016-0302-1","volume":"15","author":"J Wattacheril","year":"2016","unstructured":"Wattacheril J, Sanyal AJ. Lean NAFLD: an underrecognized outlier. Curr Hepatol Rep. 2016;15:134\u20139.","journal-title":"Curr Hepatol Rep"},{"issue":"2","key":"5249_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41575-018-0094-6","volume":"16","author":"R Younes","year":"2019","unstructured":"Younes R, Bugianesi E. A spotlight on pathogenesis, interactions and novel therapeutic options in NAFLD. Nat Reviews Gastroenterol Hepatol. 2019;16(2):80\u20132.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"6","key":"5249_CR6","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jceh.2019.05.005","volume":"9","author":"E Fitzpatrick","year":"2019","unstructured":"Fitzpatrick E, Dhawan A. Childhood and adolescent nonalcoholic fatty liver disease: is it different from adults? J Clin Experimental Hepatol. 2019;9(6):716\u201322.","journal-title":"J Clin Experimental Hepatol"},{"issue":"9","key":"5249_CR7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","volume":"16","author":"V Nobili","year":"2019","unstructured":"Nobili V, Alisi A, Valenti L, Miele L, Feldstein AE, Alkhouri N. NAFLD in children: new genes, new diagnostic modalities and new drugs. Nat Reviews Gastroenterol Hepatol. 2019;16(9):517\u201330.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"1","key":"5249_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"key":"5249_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-017-0806-8","volume":"15","author":"BA Neuschwander-Tetri","year":"2017","unstructured":"Neuschwander-Tetri BA. Non-alcoholic fatty liver disease. BMC Med. 2017;15:1\u20136.","journal-title":"BMC Med"},{"key":"5249_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/liv.13299","volume":"37","author":"S Bellentani","year":"2017","unstructured":"Bellentani S. The epidemiology of non-alcoholic fatty liver disease. Liver Int. 2017;37:81\u20134.","journal-title":"Liver Int"},{"issue":"2","key":"5249_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1478-3231.2008.01790.x","volume":"29","author":"SM Alavian","year":"2009","unstructured":"Alavian SM, Mohammad-Alizadeh AH, Esna\u2010Ashari F, Ardalan G, Hajarizadeh B. Non\u2010alcoholic fatty liver disease prevalence among school\u2010aged children and adolescents in Iran and its association with biochemical and anthropometric measures. Liver Int. 2009;29(2):159\u201363.","journal-title":"Liver Int"},{"key":"5249_CR12","doi-asserted-by":"crossref","unstructured":"Lankarani KB, Ghaffarpasand F, Mahmoodi M, Lotfi M, Zamiri N, Heydari ST et al. Non alcoholic fatty liver disease in Southern iran: a population based study. Hepat Monthly. 2013;13(5).","DOI":"10.5812\/hepatmon.9248"},{"issue":"4","key":"5249_CR13","first-page":"377","volume":"8","author":"H Li","year":"2009","unstructured":"Li H, Wang Y-J, Tan K, Zeng L, Liu L, Liu F-J, et al. Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China. Hepatobiliary Pancreat Dis International: HBPD INT. 2009;8(4):377\u201382.","journal-title":"Hepatobiliary Pancreat Dis International: HBPD INT"},{"issue":"7","key":"5249_CR14","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322.","journal-title":"Nat Med"},{"key":"5249_CR15","doi-asserted-by":"crossref","unstructured":"Brunt EM, editor. Editor nonalcoholic steatohepatitis: pathologic features and differential diagnosis. Seminars in diagnostic pathology. Elsevier; 2005.","DOI":"10.1053\/j.semdp.2006.04.002"},{"issue":"6","key":"5249_CR16","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/hep.510300604","volume":"30","author":"P Angulo","year":"1999","unstructured":"Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999;30(6):1356\u201362.","journal-title":"Hepatology"},{"issue":"1","key":"5249_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/hep.20023","volume":"39","author":"E Bugianesi","year":"2004","unstructured":"Bugianesi E, Manzini P, D\u2019Antico S, Vanni E, Longo F, Leone N, et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology. 2004;39(1):179\u201387.","journal-title":"Hepatology"},{"issue":"1","key":"5249_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hep.28287","volume":"63","author":"C Rosso","year":"2016","unstructured":"Rosso C, Mezzabotta L, Gaggini M, Salomone F, Gambino R, Marengo A, et al. Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease. Hepatology. 2016;63(1):107\u201316.","journal-title":"Hepatology"},{"issue":"9","key":"5249_CR19","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/gut.2006.107946","volume":"56","author":"G Svegliati-Baroni","year":"2007","unstructured":"Svegliati-Baroni G, Bugianesi E, Bouserhal T, Marini F, Ridolfi F, Tarsetti F, et al. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease. Gut. 2007;56(9):1296\u2013301.","journal-title":"Gut"},{"key":"5249_CR20","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","volume":"48","author":"E Bugianesi","year":"2005","unstructured":"Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia. 2005;48:634\u201342.","journal-title":"Diabetologia"},{"issue":"3","key":"5249_CR21","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/hep.22429","volume":"48","author":"AL Fracanzani","year":"2008","unstructured":"Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008;48(3):792\u20138.","journal-title":"Hepatology"},{"issue":"4","key":"5249_CR22","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1053\/jhep.2001.28055","volume":"34","author":"V Paradis","year":"2001","unstructured":"Paradis V, Perlemuter G, Bonvoust F, Dargere D, Parfait B, Vidaud M, et al. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology. 2001;34(4):738\u201344.","journal-title":"Hepatology"},{"issue":"11","key":"5249_CR23","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.2337\/diabetes.54.11.3140","volume":"54","author":"AJ Hanley","year":"2005","unstructured":"Hanley AJ, Williams K, Festa A, Wagenknecht LE, D\u2019Agostino RB Jr, Haffner SM. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes. 2005;54(11):3140\u20137.","journal-title":"Diabetes"},{"issue":"6","key":"5249_CR24","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/j.1440-1746.2004.03362.x","volume":"19","author":"SH Park","year":"2004","unstructured":"Park SH, Kim BI, Yun JW, Kim JW, Park DI, Cho YK, et al. Insulin resistance and C-reactive protein as independent risk factors for non\u2010alcoholic fatty liver disease in non\u2010obese Asian men. J Gastroenterol Hepatol. 2004;19(6):694\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"5249_CR25","doi-asserted-by":"crossref","unstructured":"Day CP, James OF. Steatohepatitis: a Tale of two hits? Elsevier; 1998. pp. 842\u20135.","DOI":"10.1016\/S0016-5085(98)70599-2"},{"issue":"3","key":"5249_CR26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.yexmp.2015.11.008","volume":"99","author":"G Aljomah","year":"2015","unstructured":"Aljomah G, Baker SS, Liu W, Kozielski R, Oluwole J, Lupu B, et al. Induction of CYP2E1 in non-alcoholic fatty liver diseases. Exp Mol Pathol. 2015;99(3):677\u201381.","journal-title":"Exp Mol Pathol"},{"key":"5249_CR27","doi-asserted-by":"publisher","first-page":"603926","DOI":"10.3389\/fphar.2020.603926","volume":"11","author":"C Peng","year":"2020","unstructured":"Peng C, Stewart AG, Woodman OL, Ritchie RH, Qin CX. Non-alcoholic steatohepatitis: a review of its mechanism, models and medical treatments. Front Pharmacol. 2020;11:603926.","journal-title":"Front Pharmacol"},{"key":"5249_CR28","doi-asserted-by":"crossref","unstructured":"Kazemi M, Eshraghi A, Yegdaneh A, Ghannadi A. Clinical pharmacognosy-A new interesting era of pharmacy in the third millennium. Springer; 2012. pp. 1\u20133.","DOI":"10.1186\/2008-2231-20-18"},{"issue":"1","key":"5249_CR29","first-page":"217","volume":"4","author":"MS Sharifi","year":"2012","unstructured":"Sharifi MS, Hazell SL. Isolation, analysis and antimicrobial activity of the acidic fractions of Mastic, Kurdica, mutica and Cabolica gums from genus pistacia. Global J Health Sci. 2012;4(1):217.","journal-title":"Global J Health Sci"},{"issue":"4","key":"5249_CR30","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/ffj.1445","volume":"20","author":"FB Douissa","year":"2005","unstructured":"Douissa FB, Hayder N, Chekir-Ghedira L, Hammami M, Ghedira K, Mariotte AM, et al. New study of the essential oil from leaves of pistacia lentiscus L.(Anacardiaceae) from Tunisia. Flavour Fragr J. 2005;20(4):410\u20134.","journal-title":"Flavour Fragr J"},{"issue":"3","key":"5249_CR31","first-page":"108","volume":"2","author":"P Aghaei","year":"2013","unstructured":"Aghaei P, Bahramnejad B, Mozafari A. Effect of different plant growth regulators on callus induction of stem explants in\u2019pistacia atlantica\u2019subsp. Kurdica. Plant Knowl J. 2013;2(3):108\u201312.","journal-title":"Plant Knowl J"},{"issue":"2","key":"5249_CR32","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.tiv.2009.06.024","volume":"24","author":"W Bhouri","year":"2010","unstructured":"Bhouri W, Derbel S, Skandrani I, Boubaker J, Bouhlel I, Sghaier MB, et al. Study of genotoxic, antigenotoxic and antioxidant activities of the digallic acid isolated from pistacia lentiscus fruits. Toxicol in Vitro. 2010;24(2):509\u201315.","journal-title":"Toxicol in Vitro"},{"issue":"1","key":"5249_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jep.2004.03.033","volume":"93","author":"I Hamdan","year":"2004","unstructured":"Hamdan I, Afifi F. Studies on the in vitro and in vivo hypoglycemic activities of some medicinal plants used in treatment of diabetes in Jordanian traditional medicine. J Ethnopharmacol. 2004;93(1):117\u201321.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"5249_CR34","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.eujim.2015.03.009","volume":"7","author":"S Remila","year":"2015","unstructured":"Remila S, Atmani-Kilani D, Delemasure S, Connat J-L, Azib L, Richard T, et al. Antioxidant, cytoprotective, anti-inflammatory and anticancer activities of pistacia lentiscus (Anacardiaceae) leaf and fruit extracts. Eur J Integr Med. 2015;7(3):274\u201386.","journal-title":"Eur J Integr Med"},{"issue":"1","key":"5249_CR35","first-page":"36","volume":"39","author":"M Taran","year":"2010","unstructured":"Taran M, Mohebali M, Esmaeli J. In vivo efficacy of gum obtained pistacia Atlantica in experimental treatment of cutaneous leishmaniasis. Iran J Public Health. 2010;39(1):36\u201341.","journal-title":"Iran J Public Health"},{"issue":"3\u20134","key":"5249_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0964-8305(95)00103-4","volume":"36","author":"CC Tassou","year":"1995","unstructured":"Tassou CC, Nychas G. Antimicrobial activity of the essential oil of mastic gum (Pistacia lentiscus var. chia) on gram positive and gram negative bacteria in broth and in model food system. Int Biodeterior Biodegrad. 1995;36(3\u20134):411\u201320.","journal-title":"Int Biodeterior Biodegrad"},{"issue":"3\u20134","key":"5249_CR37","first-page":"9","volume":"19","author":"HO Dyary","year":"2017","unstructured":"Dyary HO, Rahman HS, Othman HH, Hassan SMA, Abdullah R. Acute toxicity of pistacia Atlantica green seeds on Sprague-Dawley rat model. J Zankoy Sulaimani. 2017;19(3\u20134):9\u201316.","journal-title":"J Zankoy Sulaimani"},{"key":"5249_CR38","unstructured":"Amin G. Medicinal plants of Iran. Tehran University Publication, Tehran, Iran; 2005."},{"issue":"2","key":"5249_CR39","first-page":"73","volume":"62","author":"Y Dogan","year":"2003","unstructured":"Dogan Y, Baslar S, Ayden H, Mert HH. A study of the soil-plant interactions of pistacia lentiscus L. distributed in the Western Anatolian part of Turkey. Acta Bot Croatica. 2003;62(2):73\u201388.","journal-title":"Acta Bot Croatica"},{"key":"5249_CR40","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1023\/A:1013766400932","volume":"37","author":"F Demirci","year":"2001","unstructured":"Demirci F, Baser K, Calis I, Gokhan E. Essential oil and antimicrobial evaluation of the pistacia Eurycarpa. Chem Nat Compd. 2001;37:332\u20135.","journal-title":"Chem Nat Compd"},{"issue":"08","key":"5249_CR41","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1055\/s-2006-960856","volume":"65","author":"P Magiatis","year":"1999","unstructured":"Magiatis P, Melliou E, Skaltsounis A-L, Chinou IB, Mitaku S. Chemical composition and antimicrobial activity of the essential oils of pistacia lentiscus var. Chia. Planta Med. 1999;65(08):749\u201352.","journal-title":"Planta Med"},{"issue":"8","key":"5249_CR42","first-page":"1364","volume":"3","author":"MS Sharifi","year":"2011","unstructured":"Sharifi MS, Hazell SL. GC-MS analysis and antimicrobial activity of the essential oil of the trunk exudates from pistacia Atlantica Kurdica. J Pharm Sci Res. 2011;3(8):1364.","journal-title":"J Pharm Sci Res"},{"key":"5249_CR43","unstructured":"Sharifi MS. Fractionations and analysis of trunk exudates from pistacia genus in relation to antimicrobial activity. 2006.Western Sydney University thesis. http:\/\/handle.uws.edu.au:8081\/1959.7\/35517}"},{"issue":"1","key":"5249_CR44","first-page":"646","volume":"7","author":"M Bahmani","year":"2015","unstructured":"Bahmani M, Saki K, Asadbeygi M, Adineh A, Saberianpour S, Rafieian-Kopaei M, et al. The effects of nutritional and medicinal mastic herb (Pistacia atlantica). J Chem Pharm Res. 2015;7(1):646\u201353.","journal-title":"J Chem Pharm Res"},{"issue":"7","key":"5249_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5539\/gjhs.v7n7p32","volume":"7","author":"M Tolooei","year":"2015","unstructured":"Tolooei M, Mirzaei A. Effects of pistacia Atlantica extract on erythrocyte membrane rigidity, oxidative stress, and hepatotoxicity induced by CCl4 in rats. Global J Health Sci. 2015;7(7):32.","journal-title":"Global J Health Sci"},{"key":"5249_CR46","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00580-015-2068-1","volume":"24","author":"M Hashemnia","year":"2015","unstructured":"Hashemnia M, Nikousefat Z, Yazdani-Rostam M. Antidiabetic effect of pistacia Atlantica and amygdalus scoparia in streptozotocin-induced diabetic mice. Comp Clin Pathol. 2015;24:1301\u20136.","journal-title":"Comp Clin Pathol"},{"issue":"2","key":"5249_CR47","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jep.2010.11.025","volume":"133","author":"V Kasabri","year":"2011","unstructured":"Kasabri V, Afifi FU, Hamdan I. In vitro and in vivo acute antihyperglycemic effects of five selected Indigenous plants from Jordan used in traditional medicine. J Ethnopharmacol. 2011;133(2):888\u201396.","journal-title":"J Ethnopharmacol"},{"issue":"12","key":"5249_CR48","first-page":"117","volume":"63","author":"SAA Hussein","year":"2020","unstructured":"Hussein SAA, El-Mesallamy A, Othman SO, Soliman A-MM, Erratum. Identification of novel polyphenolic secondary metabolites from pistacia Atlantica Desf. And demonstration of their cytotoxicity And CCl4 induced hepatotoxicity in rat. Egypt J Chem. 2020;63(12):117\u201330.","journal-title":"Egypt J Chem"},{"issue":"1","key":"5249_CR49","first-page":"17","volume":"22","author":"H Norasteh","year":"2020","unstructured":"Norasteh H, Mohammadi S, Nikravesh M, Taraz Jamshidi S. Protective effect of Bene (Pistacia atlantica) on busulfan-induced renal-liver injury in laboratory mice. J Babol Univ Med Sci. 2020;22(1):17\u201323.","journal-title":"J Babol Univ Med Sci"},{"key":"5249_CR50","unstructured":"Omidi H, Omidi H, Naghdi Badi H. The Effect of Pistacia atlantica Nut Powder on Liver Phosphatidate Phosphohydrolase and Serum Lipid Profile in Rat. J. Med. Plants 2008;7(26):70\u201378. http:\/\/jmp.ir\/article-1-476-en.html."},{"issue":"2","key":"5249_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.18869\/acadpub.aassjournal.2.2.13","volume":"2","author":"P Farzanegi","year":"2014","unstructured":"Farzanegi P, Ghanbari-Niaki A, Mohseni A, Haghayeghi M. Pistacia Atlantica extract enhances Exercise-Mediated improvement of antioxidant defense in Vistar rats. Annals Appl Sport Sci. 2014;2(2):13\u201322.","journal-title":"Annals Appl Sport Sci"},{"issue":"12","key":"5249_CR52","first-page":"1255","volume":"21","author":"S Jamshidi","year":"2018","unstructured":"Jamshidi S, Hejazi N, Golmakani MT, Tanideh N. Wild pistachio (Pistacia Atlantica mutica) oil improve metabolic syndrome features in rats with high Fructose ingestion. Iran J Basic Med Sci. 2018;21(12):1255\u201361.","journal-title":"Iran J Basic Med Sci"},{"key":"5249_CR53","doi-asserted-by":"publisher","first-page":"e1238","DOI":"10.31661\/gmj.v8i0.1238","volume":"8","author":"S Jamshidi","year":"2019","unstructured":"Jamshidi S, Hejazi N, Golmakani MT, Tanideh N, Heidari Esfahani M. Preventive effect of different wild pistachio oils on oxidative stress Markers, liver Enzymes, and histopathological findings in a metabolic syndrome model. Galen Med J. 2019;8:e1238.","journal-title":"Galen Med J"},{"key":"5249_CR54","doi-asserted-by":"publisher","unstructured":"Rahman HS. Phytochemical analysis and antioxidant and anticancer activities of mastic gum resin from Pistacia atlantica subspecies kurdica. Onco Targets Ther. 2018;11:4559\u20134572. https:\/\/doi.org\/10.2147\/OTT.S170827.","DOI":"10.2147\/OTT.S170827"},{"key":"5249_CR55","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00592-017-1098-3","volume":"55","author":"S Seyyedebrahimi","year":"2018","unstructured":"Seyyedebrahimi S, Khodabandehloo H, Nasli Esfahani E, Meshkani R. The effects of Resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. Acta Diabetol. 2018;55:341\u201353.","journal-title":"Acta Diabetol"},{"key":"5249_CR56","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/liv.13643","volume":"38","author":"AR Ara\u00fajo","year":"2018","unstructured":"Ara\u00fajo AR, Rosso N, Bedogni G, Tiribelli C, Bellentani S. Global epidemiology of non-alcoholic fatty liver disease\/non\u2010alcoholic steatohepatitis: what we need in the future. Liver Int. 2018;38:47\u201351.","journal-title":"Liver Int"},{"issue":"2","key":"5249_CR57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27\u201331.","journal-title":"J Basic Clin Pharm"},{"issue":"7","key":"5249_CR58","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","volume":"85","author":"A Katz","year":"2000","unstructured":"Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metabolism. 2000;85(7):2402\u201310.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"5249_CR59","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor B, Treacher DF, Turner R. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139.","journal-title":"Diabetologia"},{"issue":"8","key":"5249_CR60","first-page":"1073","volume":"18","author":"MB Moghaddam","year":"2012","unstructured":"Moghaddam MB, Aghdam FB, Jafarabadi MA, Allahverdipour H, Nikookheslat SD, Safarpour S. The Iranian version of international physical activity questionnaire (IPAQ) in iran: content and construct validity, factor structure, internal consistency and stability. World Appl Sci J. 2012;18(8):1073\u201380.","journal-title":"World Appl Sci J"},{"issue":"1","key":"5249_CR61","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol"},{"issue":"4","key":"5249_CR62","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793\u2013801.","journal-title":"J Hepatol"},{"issue":"5","key":"5249_CR63","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/jgh.13264","volume":"31","author":"S Ballestri","year":"2016","unstructured":"Ballestri S, Zona S, Targher G, Romagnoli D, Baldelli E, Nascimbeni F, et al. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31(5):936\u201344.","journal-title":"J Gastroenterol Hepatol"},{"key":"5249_CR64","doi-asserted-by":"publisher","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","volume":"111","author":"A Mantovani","year":"2020","unstructured":"Mantovani A, Scorletti E, Mosca A, Alisi A, Byrne CD, Targher G. Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism. 2020;111:154170.","journal-title":"Metabolism"},{"issue":"10290","key":"5249_CR65","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW-S, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"key":"5249_CR66","doi-asserted-by":"publisher","unstructured":"Petroni M L, Brodosi L, Bugianesi E, Marchesini G. Management of non-alcoholic fatty liver disease BMJ 2021; 372 :m4747. https:\/\/doi.org\/10.1136\/bmj.m4747}","DOI":"10.1136\/bmj.m4747"},{"issue":"4","key":"5249_CR67","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3892\/ijmm.2024.5412","volume":"54","author":"J Sun","year":"2024","unstructured":"Sun J, Jin X, Li Y. Current strategies for nonalcoholic fatty liver disease treatment. Int J Mol Med. 2024;54(4):88.","journal-title":"Int J Mol Med"},{"issue":"2","key":"5249_CR68","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cld.2023.01.002","volume":"27","author":"F Bril","year":"2023","unstructured":"Bril F, Sanyal A, Cusi K. Metabolic syndrome and its association with nonalcoholic steatohepatitis. Clin Liver Dis. 2023;27(2):187\u2013210.","journal-title":"Clin Liver Dis"},{"issue":"4","key":"5249_CR69","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","volume":"142","author":"K Cusi","year":"2012","unstructured":"Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology. 2012;142(4):711\u201325. e6.","journal-title":"Gastroenterology"},{"issue":"4","key":"5249_CR70","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jhepr.2019.07.002","volume":"1","author":"A Gastaldelli","year":"2019","unstructured":"Gastaldelli A, Cusi K. From NASH to diabetes and from diabetes to NASH: mechanisms and treatment options. JHEP Rep. 2019;1(4):312\u201328.","journal-title":"JHEP Rep"},{"issue":"4","key":"5249_CR71","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","volume":"76","author":"E Scorletti","year":"2022","unstructured":"Scorletti E, Carr RM. A new perspective on NAFLD: focusing on lipid droplets. J Hepatol. 2022;76(4):934\u201345.","journal-title":"J Hepatol"},{"issue":"12","key":"5249_CR72","first-page":"821","volume":"53","author":"S Li","year":"2012","unstructured":"Li S, Huang S, Mo ZN, Gao Y, Yang XB, Chen XJ, et al. Generating a reference interval for fasting serum insulin in healthy nondiabetic adult Chinese men. Singapore Med J. 2012;53(12):821\u20135.","journal-title":"Singapore Med J"},{"issue":"4","key":"5249_CR73","doi-asserted-by":"publisher","first-page":"604","DOI":"10.18295\/squmj.4.2021.030","volume":"21","author":"A Abdesselam","year":"2021","unstructured":"Abdesselam A, Zidoum H, Zadjali F, Hedjam R, Al-Ansari A, Bayoumi R, et al. Estimate of the HOMA-IR Cut-off value for identifying subjects at risk of insulin resistance using a machine learning approach. Sultan Qaboos Univ Med J. 2021;21(4):604\u201312.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"5249_CR74","doi-asserted-by":"publisher","first-page":"1100547","DOI":"10.3389\/fmed.2023.1100547","volume":"10","author":"A Biernacka-Bartnik","year":"2023","unstructured":"Biernacka-Bartnik A, Koce\u0142ak P, Owczarek AJ, Chor\u0119za PS, Markuszewski L, Madej P, et al. The cut-off value for HOMA-IR discriminating the insulin resistance based on the SHBG level in women with polycystic ovary syndrome. Front Med. 2023;10:1100547.","journal-title":"Front Med"},{"issue":"3","key":"5249_CR75","first-page":"655","volume":"13","author":"TO Akande","year":"2013","unstructured":"Akande TO, Adeleye JO, Kadiri S. Insulin resistance in Nigerians with essential hypertension. Afr Health Sci. 2013;13(3):655\u201360.","journal-title":"Afr Health Sci"},{"issue":"4","key":"5249_CR76","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4274\/Jcrpe.1127","volume":"5","author":"Y Singh","year":"2013","unstructured":"Singh Y, Garg M, Tandon N, Marwaha RK. A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents. J Clin Res Pediatr Endocrinol. 2013;5(4):245\u201351.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"5249_CR77","doi-asserted-by":"publisher","first-page":"113329","DOI":"10.1016\/j.jep.2020.113329","volume":"265","author":"Z Ben Ahmed","year":"2021","unstructured":"Ben Ahmed Z, Yousfi M, Viaene J, Dejaegher B, Demeyer K, Heyden YV. Four pistacia Atlantica subspecies (atlantica, cabulica, Kurdica and mutica): A review of their botany, ethnobotany, phytochemistry and Pharmacology. J Ethnopharmacol. 2021;265:113329.","journal-title":"J Ethnopharmacol"},{"key":"5249_CR78","doi-asserted-by":"publisher","first-page":"101613","DOI":"10.1016\/j.ctcp.2022.101613","volume":"48","author":"FS Majd","year":"2022","unstructured":"Majd FS, Talebi SS, Ahmad Abadi AN, Poorolajal J, Dastan D. Efficacy of a standardized herbal product from pistacia Atlantica subsp. Kurdica in type 2 diabetic patients with hyperlipidemia: A triple-blind randomized clinical trial. Complement Ther Clin Pract. 2022;48:101613.","journal-title":"Complement Ther Clin Pract"},{"key":"5249_CR79","doi-asserted-by":"publisher","unstructured":"Hosseini S, Nili-Ahmadabadi A, Nachvak SM, et al. Antihyperlipidemic and Antioxidative Properties of Pistacia atlantica subsp. kurdica in Streptozotocin-Induced Diabetic Mice. Diabetes Metab Syndr Obes. 2020;13:1231-1236. https:\/\/doi.org\/10.2147\/DMSO.S250417.","DOI":"10.2147\/DMSO.S250417"},{"issue":"7","key":"5249_CR80","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1177\/2047487315603186","volume":"23","author":"A Kartalis","year":"2016","unstructured":"Kartalis A, Didagelos M, Georgiadis I, Benetos G, Smyrnioudis N, Marmaras H, et al. Effects of Chios mastic gum on cholesterol and glucose levels of healthy volunteers: A prospective, randomized, placebo-controlled, pilot study (CHIOS-MASTIHA). Eur J Prev Cardiol. 2016;23(7):722\u20139.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"5249_CR81","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jep.2006.10.031","volume":"111","author":"A Triantafyllou","year":"2007","unstructured":"Triantafyllou A, Chaviaras N, Sergentanis TN, Protopapa E, Tsaknis J. Chios mastic gum modulates serum biochemical parameters in a human population. J Ethnopharmacol. 2007;111(1):43\u20139.","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"5249_CR82","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.19082\/6997","volume":"10","author":"F Mahjoub","year":"2018","unstructured":"Mahjoub F, Salari R, Yousefi M, Mohebbi M, Saki A, Rezayat KA. Effect of pistacia Atlantica Kurdica gum on diabetic gastroparesis symptoms: a randomized, triple-blind placebo-controlled clinical trial. Electron Physician. 2018;10(7):6997\u20137007.","journal-title":"Electron Physician"},{"issue":"1","key":"5249_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/jmf.2014.0021","volume":"18","author":"I Georgiadis","year":"2015","unstructured":"Georgiadis I, Karatzas T, Korou LM, Katsilambros N, Perrea D. Beneficial health effects of Chios gum mastic and peroxisome proliferator-activated receptors: indications of common mechanisms. J Med Food. 2015;18(1):1\u201310.","journal-title":"J Med Food"},{"key":"5249_CR84","first-page":"7","volume":"55","author":"H \u00d6zbek","year":"2017","unstructured":"\u00d6zbek H, Yilmaz B. Anti-inflammatory and hypoglycemic activities of alpha-pinene. ACTA Pharm Sciencia. 2017;55:7.","journal-title":"ACTA Pharm Sciencia"},{"issue":"1","key":"5249_CR85","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bcp.2011.08.010","volume":"83","author":"M Russo","year":"2012","unstructured":"Russo M, Spagnuolo C, Tedesco I, Bilotto S, Russo GL. The flavonoid Quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol. 2012;83(1):6\u201315.","journal-title":"Biochem Pharmacol"},{"key":"5249_CR86","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jpba.2017.11.049","volume":"149","author":"ZB Ahmed","year":"2018","unstructured":"Ahmed ZB, Yousfi M, Viaene J, Dejaegher B, Demeyer K, Mangelings D, et al. Potentially antidiabetic and antihypertensive compounds identified from pistacia Atlantica leaf extracts by LC fingerprinting. J Pharm Biomed Anal. 2018;149:547\u201356.","journal-title":"J Pharm Biomed Anal"},{"issue":"15","key":"5249_CR87","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3748\/wjg.15.1809","volume":"15","author":"N Assy","year":"2009","unstructured":"Assy N, Nassar F, Nasser G, Grosovski M. Olive oil consumption and non-alcoholic fatty liver disease. World J Gastroenterol. 2009;15(15):1809\u201315.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"5249_CR88","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3945\/an.116.014506","volume":"8","author":"E Cava","year":"2017","unstructured":"Cava E, Yeat NC, Mittendorfer B. Preserving healthy muscle during weight loss. Adv Nutr. 2017;8(3):511\u20139.","journal-title":"Adv Nutr"},{"issue":"Suppl","key":"5249_CR89","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.3350\/cmh.2022.0358","volume":"29","author":"SK Joo","year":"2022","unstructured":"Joo SK, Kim W. Interaction between sarcopenia and nonalcoholic fatty liver disease. Clin Mol Hepatol. 2022;29(Suppl):S68.","journal-title":"Clin Mol Hepatol"},{"issue":"7","key":"5249_CR90","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s11739-023-03339-z","volume":"18","author":"G Tarantino","year":"2023","unstructured":"Tarantino G, Sinatti G, Citro V, Santini SJ, Balsano C. Sarcopenia, a condition shared by various diseases: can we alleviate or delay the progression? Intern Emerg Med. 2023;18(7):1887\u201395.","journal-title":"Intern Emerg Med"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-026-05249-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05249-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05249-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:10:51Z","timestamp":1787584251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12906-026-05249-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5249"],"URL":"https:\/\/doi.org\/10.1186\/s12906-026-05249-x","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article is taken from student Ph.D. thesis. The trial was given ethical approval by the Ethics Committee of the Deputy of Research and Technology of Kermanshah University of Medical Sciences (ethics approval number: IR.KUMS.REC.1402.442) and registered with the Iranian Clinical Trials Registry (registration number IRCT: IRCT20231219060466N1). Informed consent to participate was obtained from all of the participants in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"257"}}